OncoMatch

OncoMatch/Clinical Trials/NCT04263025

AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft

Is NCT04263025 recruiting? Yes, currently enrolling (May 2026). This Phase 2/3 trial studies Cryopreserved Umbilical Cord Allograft for prostate cancer.

Phase 2/3RecruitingHackensack Meridian HealthNCT04263025Data as of May 2026

Treatment: Cryopreserved Umbilical Cord AllograftThis study aims at evaluating if placement of CLARIX® CORD 1K during robotic prostatectomy decreases the time to achieve complete erectile and urinary function after the surgery. As part of the study, the patient will be asked to answer various questions after the surgery regarding sexual and urinary function.

Check if I qualify

Extracted eligibility criteria

Cancer type

Prostate Cancer

Prior therapy

Cannot have received: pelvic radiation

Previous history of pelvic radiation

Cannot have received: simple prostatectomy or transurethral prostate surgery

Previous history of simple prostatectomy or transurethral prostate surgery

Cannot have received: systemic therapy for prostate cancer

Previous history of systemic therapy for prostate cancer

Cannot have received: open pelvic surgery

Exception: hernia repair

History of open pelvic surgery within 5 years except for hernia repair

Cannot have received: chemotherapy

Scheduled at the time of screening to undergo chemotherapy, radiation, hormone therapy, or open surgery during the study period.

Cannot have received: radiation

Scheduled at the time of screening to undergo chemotherapy, radiation, hormone therapy, or open surgery during the study period.

Cannot have received: hormone therapy

Scheduled at the time of screening to undergo chemotherapy, radiation, hormone therapy, or open surgery during the study period.

Cannot have received: open surgery

Scheduled at the time of screening to undergo chemotherapy, radiation, hormone therapy, or open surgery during the study period.

Structured fields extracted by AI. May contain errors — verify against the official protocol.

US trial sites

  • Hackensack University Medical Center · Hackensack, New Jersey

Showing up to 5 US sites. See all sites on ClinicalTrials.gov →

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify